- Trials with a EudraCT protocol (162)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
162 result(s) found for: Metabolic Syndrome X.
Displaying page 1 of 9.
EudraCT Number: 2010-022308-34 | Sponsor Protocol Number: JW/IB/AG | Start Date*: 2011-04-19 | ||||||||||||||||
Sponsor Name:Central Manchester Foundation Hospitals Trust | ||||||||||||||||||
Full Title: Eplerenone in Metabolic Syndrome: An investigation into the effects of Eplerenone on perivascular adipose tissue and small artery tone in obesity | ||||||||||||||||||
Medical condition: Obesity and Metabolic Syndrome (combination of obesity, hypertension, raised blood glucose and cholesterol abnormalities) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-004934-40 | Sponsor Protocol Number: 20072651 | Start Date*: 2021-03-19 | |||||||||||
Sponsor Name:Department of Endocrinology and Internal Medicine, Aarhus University Hospital | |||||||||||||
Full Title: Endocrine, cardiovascular, pharmacologic and physiologic aspects of sex hormone treatment in Turner syndrome - project part B | |||||||||||||
Medical condition: Ovarian dysgenesis and related hypogonadism causes by Turner syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-005708-18 | Sponsor Protocol Number: 14081962 | Start Date*: 2010-06-04 |
Sponsor Name:Queen Mary University of London | ||
Full Title: Prevention of metabolic complications of glucocorticoid excess | ||
Medical condition: Rheumatoid arthritis, SLE, Polymyalgia rheumatica, Disthyroid eye disease, Cushing's syndrome | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-003567-31 | Sponsor Protocol Number: KPUK0106 | Start Date*: 2007-05-25 | ||||||||||||||||
Sponsor Name:Med. Klinik II, Grosshadern, Klinikum der Universität München | ||||||||||||||||||
Full Title: Regulation of Inflammatory Parameters by Telmisartan in Hypertensive Patients | ||||||||||||||||||
Medical condition: hypertension metabolic syndrome | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Ongoing) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2005-002568-27 | Sponsor Protocol Number: PM-C-0172 | Start Date*: 2006-05-08 | |||||||||||
Sponsor Name:Sanofi-Synthelabo Groupe | |||||||||||||
Full Title: A randomized, double blind, two-arm placebo controlled, 12-Month study of the effects of rimonabant 20mg once daily on the amount and the activity of visceral fat in abdominally obese patients with... | |||||||||||||
Medical condition: Abdominally obese patients with metabolic syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) ES (Completed) DK (Completed) SE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-003130-41 | Sponsor Protocol Number: DSE-866/46 | Start Date*: 2008-06-30 | ||||||||||||||||
Sponsor Name:DAIICHI-SANKYO EUROPE GmbH | ||||||||||||||||||
Full Title: Effect of Olmesartan Medoxomil on Vascular Markers in Hypertensive Patients with Metabolic Syndrome | ||||||||||||||||||
Medical condition: Metabolic Syndrome Hypertension | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-006165-18 | Sponsor Protocol Number: FEN | Start Date*: 2012-06-20 |
Sponsor Name:Academic Medical Center | ||
Full Title: A randomized double blind placebo controlled study on the effects of fenretinide Lym-X-Sorb on insulin sensitivity in obese insulin resistant subjects | ||
Medical condition: Obesity Metabolic syndrome X Insulin resistance Fatty liver | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-003177-58 | Sponsor Protocol Number: SPIOMET4HEALTH | Start Date*: 2022-05-12 | |||||||||||
Sponsor Name:Fundació Sant Joan de Déu (FSJD) | |||||||||||||
Full Title: A Phase II, randomised, multi-centric, multi-national clinical trial to evaluate the efficacy, tolerability, and safety of a fixed dose combination of Spironolactone, Pioglitazone & Metformin (SPIO... | |||||||||||||
Medical condition: Polycystic Ovary Syndrome (PCOS) | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Female | ||||||||||||
Trial protocol: AT (Ongoing) NO (Ongoing) IT (Ongoing) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-001217-42 | Sponsor Protocol Number: CN138-489 | Start Date*: 2007-09-20 | |||||||||||
Sponsor Name:Bristol Myers Squibb International Corporation | |||||||||||||
Full Title: A 16-Week, Multicenter, Randomized, Open-label Study to Assess the Effects of Aripiprazole versus other Atypical Antipsychotics in the Treatment of Schizophrenic Patients with Metabolic Syndrome | |||||||||||||
Medical condition: Subjects with schizophrenia who developed metabolic syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) HU (Prematurely Ended) GR (Prematurely Ended) CZ (Completed) ES (Completed) BE (Completed) DK (Prematurely Ended) DE (Prematurely Ended) FI (Prematurely Ended) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-000460-10 | Sponsor Protocol Number: EMR200104_10 | Start Date*: 2011-08-03 | ||||||||||||||||
Sponsor Name:Merck Serono SA | ||||||||||||||||||
Full Title: First year growth response associated genetic markers validation Phase IV open-label study in Growth Hormone Deficient and Turner Syndrome pre-pubertal children : the PREDICT Pharmacogenetics V... | ||||||||||||||||||
Medical condition: idiopathic growth hormone deficienty Turner Syndrome | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) ES (Completed) CZ (Completed) IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-005313-39 | Sponsor Protocol Number: LAN-HD-ACRO | Start Date*: 2013-05-17 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA Spedali Civili di Brescia | |||||||||||||
Full Title: Scheme of treatment with high-dose lanreotide in acromegalic patients poorly responsive to treatment with standard doses." | |||||||||||||
Medical condition: acromegaly | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-003250-23 | Sponsor Protocol Number: 78162.018.21 | Start Date*: Information not available in EudraCT | ||||||||||||||||
Sponsor Name:Amsterdam UMC | ||||||||||||||||||
Full Title: Cannabidiol (Epidyolex) for behavioural problems in patients with Tuberous Sclerosis Complex, Sanfilippo and Fragile X Syndrome: an N-of-1 series | ||||||||||||||||||
Medical condition: Tuberous Sclerosis Complex (TSC), Sanfilippo syndrome, Fragile X syndrome (FXS) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-003131-23 | Sponsor Protocol Number: DSE-866/47 | Start Date*: 2008-07-28 | ||||||||||||||||
Sponsor Name:DAIICHI SANKYO EUROPE GmbH | ||||||||||||||||||
Full Title: Effect of Olmesartan Medoxomil on Arterial Stiffness and Thickness in Subjects with Metabolic Syndrome | ||||||||||||||||||
Medical condition: Metabolic Syndrome, Hypertension | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Completed) FR (Completed) DE (Completed) GB (Completed) IT (Completed) NL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-003599-39 | Sponsor Protocol Number: SAKK08/15 | Start Date*: 2017-12-13 |
Sponsor Name:Swiss Group for Clinical Cancer Research (SAKK) | ||
Full Title: PROMET - Multicenter, Randomized Phase II Trial of Salvage Radiotherapy +/- Metformin for Patients with Prostate Cancer after Prostatectomy | ||
Medical condition: Histologically confirmed adenocarcinoma of the prostate without small cell features with PSA progression after radical prostatectomy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: DE (Completed) FR (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-001452-30 | Sponsor Protocol Number: 010815testis | Start Date*: 2015-12-07 | |||||||||||
Sponsor Name:Copenhagen University Hospital Rigshospitalet | |||||||||||||
Full Title: A Randomized double-blind study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig Cell Insufficiency (Einstein-intervention) | |||||||||||||
Medical condition: Leydig Cell dysfunction | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-015982-29 | Sponsor Protocol Number: UMCU-Vasc-14A | Start Date*: 2010-07-27 | ||||||||||||||||||||||||||
Sponsor Name:University Medical Center Utrecht | ||||||||||||||||||||||||||||
Full Title: A randomized, placebo-controlled, double blind, 4-period, cross-over trial, to study the effects of aliskiren, hydrochlorothiazide and moxonidine on endothelial dysfunction in obesity related hyper... | ||||||||||||||||||||||||||||
Medical condition: Hypertension in subjects with abdominal obesity and the metabolic syndrome | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male | |||||||||||||||||||||||||||
Trial protocol: NL (Completed) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-001670-34 | Sponsor Protocol Number: AZP01-CLI-002 | Start Date*: 2015-01-26 | |||||||||||||||||||||
Sponsor Name:Alize Pharma | |||||||||||||||||||||||
Full Title: A Phase IIa, randomized, double-blind, placebo-controlled, multi-center study to evaluate the safety, tolerability, and effects of AZP-531, an Unacylated Ghrelin analog, on food-related behavior in... | |||||||||||||||||||||||
Medical condition: Prader-Willi Syndrome | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: ES (Completed) FR (Completed) IT (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-000441-38 | Sponsor Protocol Number: CPCRA 065 | Start Date*: 2005-04-26 |
Sponsor Name:National Institute of Allergy and Infectious Diseases, National Institutes of Health | ||
Full Title: Large, Simple Trial Comparing Two Strategies for Management of Anti-Retroviral Therapy (The SMART Study) | ||
Medical condition: HIV infection | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) IT (Prematurely Ended) IE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-000102-33 | Sponsor Protocol Number: 69HCL16_0079 | Start Date*: 2018-03-22 | |||||||||||
Sponsor Name:Hospices Civils de Lyon | |||||||||||||
Full Title: Effectiveness of Intravenous Immunoglobulins (IVIG) in Toxic Shock Syndromes in children: a multicenter European randomized controlled trial | |||||||||||||
Medical condition: toxic shock syndrome | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Not Authorised) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-004430-96 | Sponsor Protocol Number: 201600107 | Start Date*: 2017-12-11 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: Short-term Testosterone replacement in testicular cancer survivors to treat overweight and improve cardiometabolic risk | ||
Medical condition: Testicular cancer | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.